{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:13:19Z","timestamp":1781712799672,"version":"3.54.5"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To evaluate spectral domain optical coherence tomography (SD-OCT) features of vitreoretinal lymphoma (VRL).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Review of records and SD-OCT images of vitreoretinal lymphoma evaluated at Ocular Oncology Service, Wills Eye Hospital between July 1, 2000, and April 1, 2019.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>There were 55 eyes of 32 patients included. At presentation, SD-OCT features included vitreous opacities (n = 36, 65%), preretinal deposits (n = 7, 13%), intraretinal deposits (n = 8, 15%), subretinal deposits (n = 20, 36%), retinal pigment epithelium abnormalities (n = 35, 64%), and subretinal pigment epithelium deposits (n = 35, 64%). Of 36 eyes with observed tumor progression, comparison (initial visit vs. time of progression) revealed more intraretinal deposits (17% vs. 50%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.005) at progression. Of 15 eyes with tumor recurrence, comparison (initial visit vs. time of recurrence) revealed more intraretinal deposits (7% vs. 47%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.04) at recurrence. At last visit, 39 eyes demonstrated tumor regression. By comparison (initial presentation vs. regression), there were less frequent vitreous opacities (67% vs. 0%, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001), intraretinal deposits (15% vs. 0%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.03), subretinal deposits (36% vs. 0%, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001), and subretinal pigment epithelium deposits (69% vs. 21%, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001) at regression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Using SD-OCT in patients with vitreoretinal lymphoma, local tumor regression correlated with a reduction in vitreous opacities, intraretinal deposits, subretinal deposits, and subretinal pigment epithelium deposits. SD-OCT is useful in judging vitreoretinal lymphoma response to therapy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000002819","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T20:32:02Z","timestamp":1588192322000},"page":"249-258","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":29,"title":["SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY FEATURES OF VITREORETINAL LYMPHOMA IN 55 EYES"],"prefix":"10.1097","volume":"41","author":[{"given":"Xiaolu","family":"Yang","sequence":"first","affiliation":[{"name":"Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania;"},{"name":"Department of Ophthalmology, Shanghai General Hospital, Shanghai, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren A.","family":"Dalvin","sequence":"additional","affiliation":[{"name":"Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania;"},{"name":"Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Mazloumi","sequence":"additional","affiliation":[{"name":"Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandor","family":"Ferenczy","sequence":"additional","affiliation":[{"name":"Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Anne S.","family":"Lim","sequence":"additional","affiliation":[{"name":"Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ancona-Lezama","sequence":"additional","affiliation":[{"name":"Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry A.","family":"Shields","sequence":"additional","affiliation":[{"name":"Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arman","family":"Mashayekhi","sequence":"additional","affiliation":[{"name":"Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol L.","family":"Shields","sequence":"additional","affiliation":[{"name":"Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,4,28]]},"reference":[{"key":"R1-20250609","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/jamaophthalmol.2013.569","article-title":"Vitreoretinal lymphoma: a 20-year review of incidence, clinical and cytologic features, treatment, and outcomes","volume":"131","author":"Levasseur","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"R2-20250609","first-page":"93","article-title":"Current concepts in diagnosing and managing primary vitreoretinal (intraocular) lymphoma","volume":"15","author":"Chan","year":"2013","journal-title":"Discov Med"},{"key":"R3-20250609","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1634\/theoncologist.2011-0210","article-title":"Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium","volume":"16","author":"Chan","year":"2011","journal-title":"Oncologist"},{"key":"R4-20250609","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0161-6420(00)00499-1","article-title":"Uveitis masquerade syndromes","volume":"108","author":"Rothova","year":"2001","journal-title":"Ophthalmology"},{"key":"R5-20250609","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10792-007-9065-6","article-title":"Biopsy techniques and yields in diagnosing primary intraocular lymphoma","volume":"27","author":"Gonzales","year":"2007","journal-title":"Int Ophthalmol"},{"key":"R6-20250609","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/eye.2012.250","article-title":"Intraocular lymphoma: a clinical perspective","volume":"27","author":"Davis","year":"2013","journal-title":"Eye"},{"key":"R7-20250609","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12348-012-0072-z","article-title":"Retinal optical coherence tomography manifestations of intraocular lymphoma","volume":"2","author":"Liu","year":"2012","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"R8-20250609","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1136\/bjophthalmol-2017-311612","article-title":"Characteristic optical coherence tomography findings in patients with primary vitreoretinal lymphoma: a novel aid to early diagnosis","volume":"102","author":"Barry","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"R9-20250609","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1007\/s00417-016-3395-x","article-title":"Optical coherence tomography manifestations of primary vitreoretinal lymphoma","volume":"254","author":"Saito","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R10-20250609","first-page":"194","article-title":"Vertical hyperreflective lesions on optical coherence tomography in vitreoretinal lymphoma","volume":"37","author":"De\u00e1k","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"R11-20250609","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/IAE.0b013e3181b408a2","article-title":"Fundus autofluorescence patterns in eyes with primary intraocular lymphoma","volume":"30","author":"Ishida","year":"2010","journal-title":"Retina"},{"key":"R12-20250609","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00417-011-1718-5","article-title":"Repeated IL-10 measurement in aqueous humor and OCT imaging are valuable tools to monitor intraocular lymphoma treated with intravitreal injections of methotrexate","volume":"250","author":"Saleh","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R13-20250609","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/IAE.0b013e31829977fa","article-title":"Fundus autofluorescence patterns in primary intraocular lymphoma","volume":"34","author":"Casady","year":"2014","journal-title":"Retina"},{"key":"R14-20250609","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1167\/iovs.04-0869","article-title":"Murine model of primary intraocular lymphoma","volume":"46","author":"Chan","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R15-20250609","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0161-6420(02)01737-2","article-title":"Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary intraocular lymphoma","volume":"110","author":"Chan","year":"2003","journal-title":"Ophthalmology"},{"key":"R16-20250609","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0002-9394(68)92065-5","article-title":"Reticulum cell sarcoma of the retina and uvea","volume":"66","author":"Vogel","year":"1968","journal-title":"Am J Ophthalmol"},{"key":"R17-20250609","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0161-6420(80)35184-1","article-title":"Ocular pathology for clinicians. 3. Intraocular reticulum cell sarcoma","volume":"87","author":"Wagoner","year":"1980","journal-title":"Ophthalmology"},{"key":"R18-20250609","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0161-6420(93)31469-7","article-title":"Intraocular lymphoma. Clinical and histopathologic diagnosis","volume":"100","author":"Whitcup","year":"1993","journal-title":"Ophthalmology"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000002819","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T16:01:23Z","timestamp":1749484883000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000002819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,28]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000002819","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4,28]]}}}